Literature DB >> 23060110

What should you know about limbic encephalitis?

Sara Machado1, Amélia Nogueira Pinto, Sarosh R Irani.   

Abstract

Autoimmune encephalitis is an inflammatory disorder characterized by a subacute impairment of short-term memory, psychiatric features and seizures. It is often associated with a variety of other neurological symptoms, and its differential diagnosis is wide, leading to challenges in its recognition. It used to be regarded as a rare disease, usually paraneoplastic and with poor prognosis. However, with the recent recognition of membrane-surface directed antibodies, it is now known that in a substantial proportion of cases there is no association with any malignancy and there is a good prognosis if treated. Hence, early recognition and prompt initiation of immunotherapies are of great importance.

Entities:  

Mesh:

Year:  2012        PMID: 23060110     DOI: 10.1590/s0004-282x2012001000012

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  11 in total

1.  Autoimmune limbic encephalitis and anesthesia.

Authors:  Chrysanthi Batistaki; Kalliopi Drachtidi; Georgia Kostopanagiotou
Journal:  J Anesth       Date:  2013-10-09       Impact factor: 2.078

2.  [Therapeutic options for autoimmune encephalomyelitis].

Authors:  N Borisow; H Prüss; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

3.  Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis.

Authors:  Binita Bhandari; Bikash Basyal; Selin Sendil; Resha Khanal; Sunita Neupane; Vinod Nookala
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-08-02

4.  Anti-leucine-rich glioma-inactivated 1 limbic encephalitis: A case report and literature review.

Authors:  Jingyao Liu; Min Li; Guibo Li; Chunkui Zhou; Rensheng Zhang
Journal:  Exp Ther Med       Date:  2015-11-13       Impact factor: 2.447

Review 5.  The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.

Authors:  Valentina Damato; Bettina Balint; Anne-Kathrin Kienzler; Sarosh R Irani
Journal:  Mov Disord       Date:  2018-09-14       Impact factor: 10.338

6.  Clinical Characteristics and Treatment Outcomes of De Novo Nonconvulsive Status Epilepticus: A Retrospective Study.

Authors:  Jung Ju Lee; Kyung Il Park; Jong Moo Park; Kyusik Kang; Ohyun Kwon; Woong Woo Lee; Byung Kun Kim
Journal:  J Clin Neurol       Date:  2021-01       Impact factor: 3.077

7.  Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations.

Authors:  Jung-Ju Lee; Soon-Tae Lee; Keun-Hwa Jung; Kon Chu; Sang Kun Lee
Journal:  Exp Neurobiol       Date:  2013-12-31       Impact factor: 3.261

Review 8.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

9.  Autoimmune limbic encephalitis: A manifestation of systemic lupus erythematosus in the central nervous system.

Authors:  Débora Bartzen Moraes Angst; Nathália Stela Visoná de Figueiredo; Valmir Passarelli; Meire Argentoni Baldocchi; Maria Sheila Guimarães Rocha; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2015 Apr-Jun

10.  Refractory and Super-refractory Status Epilepticus.

Authors:  Debopam Samanta; Lisa Garrity; Ravindra Arya
Journal:  Indian Pediatr       Date:  2020-03-15       Impact factor: 1.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.